Combining the narrow-band imaging (NBI) system and magnifying endoscopy allows simple and clear visualization of microscopic structures of the superficial mucosa and its capillary patterns, which may be useful for precise endoscopic diagnosis in the gastrointestinal tract, being more closely to histopathological diagnosis. In the non-neoplastic gastric mucosa, there have been reports showing a potential usefulness of magnifying NBI for the diagnosis of Helicobacter pylori infection, degree of histological gastritis, and intestinal metaplasia. We have shown that magnifying NBI appearances in the non-neoplastic gastric mucosa also predicts pepsinogen levels, which indicates extension of gastric atrophy in the entire stomach, and gastric cancer occurrence. Furthermore, we have shown that magnifying NBI appearances predicts the result of H. pylori treatment. Clear visualization of fine mucosal and capillary patterns, obtained by magnifying NBI, allows prediction of the histological condition, more in detail without biopsy, and it may also be useful for less invasive, and cost-effective endoscopic gastric cancer surveillance, and prediction of H. pylori eradication.

Journal Section:
Review
Keywords:
Narrow-band imaging, Stomach, Gastritis, Helicobacter pylori eradication
1.
NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65–69.
https://doi.org/10.1001%2Fjama.272.1.65
2.
Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–789.
[PubMed]
https://doi.org/10.1056%2FNEJMoa001999
3.
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, et al: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127–1131.
[PubMed]
https://doi.org/10.1056%2FNEJM199110173251603
4.
Huang JQ, Sridhar S, Chen Y, Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169–1179.
[PubMed]
https://doi.org/10.1016%2FS0016-5085%2898%2970422-6
5.
Blaser MJ, Parsonnet J: Parasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4–8.
[PubMed]
https://doi.org/10.1172%2FJCI117336
6.
Gono K, Obi T, Yamaguchi M, et al: Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 2004;9:568–577.
[PubMed]
https://doi.org/10.1117%2F1.1695563
7.
Sakaki N, Iida Y, Okazaki Y, Kawamura S, Takemoto T: Magnifying endoscopic observation of the gastric mucosa, particularly in patients with atrophic gastritis. Endoscopy 1978;10:269–274.
[PubMed]
https://doi.org/10.1055%2Fs-0028-1098307
8.
Yagi K, Nakamura A, Sekine A: Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection. J Gastroenterol Hepatol 2002;17:39–45.
[PubMed]
https://doi.org/10.1046%2Fj.1440-1746.2002.02665.x
9.
Yagi K, Nakamura A, Sekine A: Comparison between magnifying endoscopy and histological, culture and urease test findings from the gastric mucosa of the corpus. Endoscopy 2002;34:376–381.
[PubMed]
https://doi.org/10.1055%2Fs-2002-25281
10.
Nakagawa S, Kato M, Shimizu Y, et al: Relationship between histopathologic gastritis and mucosal microvascularity: observations with magnifying endoscopy. Gastrointest Endosc 2003;58:71–75.
[PubMed]
https://doi.org/10.1067%2Fmge.2003.316
11.
Anagnostopoulos GK, Yao K, Kaye P, et al: High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy 2007;39:202–207.
[PubMed]
https://doi.org/10.1055%2Fs-2006-945056
12.
Uedo N, Ishihara R, Iishi H, et al: A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006;38:819–824.
[PubMed]
https://doi.org/10.1055%2Fs-2006-944632
13.
Bansal A, Ulusarac O, Mathur S, Sharma P: Correlation between narrow-band imaging and non-neoplastic gastric pathology: a pilot feasibility trial. Gastrointest Endosc 2008;67:210–216.
[PubMed]
https://doi.org/10.1016%2Fj.gie.2007.06.009
14.
Kokkola A, Kosunen TU, Puolakkainen P, et al: Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619–624.
[PubMed]
https://doi.org/10.1034%2Fj.1600-0463.2003.1110604.x
15.
Tahara T, Shibata T, Nakamura M, et al: Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc 2009;70:246–253.
[PubMed]
https://doi.org/10.1016%2Fj.gie.2008.11.046
16.
Asaka M, Kimura T, Kudo M, et al: Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760–766.
[PubMed]
17.
Shiotani A, Iishi H, Uedo N, et al: Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 2005;115:463–469.
[PubMed]
https://doi.org/10.1002%2Fijc.20852
18.
Tahara T, Shibata T, Nakamura M, Yoshioka D, Arisawa T, Hirata I: Light blue crest sign, a favorable marker for predicting the severity of gastric atrophy in the entire stomach. Endoscopy 2008;40:880.
[PubMed]
https://doi.org/10.1055%2Fs-2008-1077582
19.
Tahara T, Shibata T, Nakamura M, et al: The mucosal pattern in the non-neoplastic gastric mucosa by using magnifying narrow-band imaging endoscopy significantly correlates with gastric cancer risk. Gastrointest Endosc 2010;71:429–430.
[PubMed]
https://doi.org/10.1016%2Fj.gie.2009.05.034
20.
Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N: Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:1923–1932.
[PubMed]
https://doi.org/10.1046%2Fj.1365-2036.2002.01346.x
21.
Asaka M, Sugiyama T, Kato M, et al: A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter2001;6:254–261.
[PubMed]
https://doi.org/10.1046%2Fj.1523-5378.2001.00037.x
© 2011 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2011
You do not currently have access to this content.